Original Research
Antibiotic use amongst pregnant women in a public hospital in KwaZulu-Natal
Submitted: 15 July 2020 | Published: 31 May 2021
About the author(s)
Sasha Naidoo, Discipline of Pharmaceutical Sciences, College of Health Sciences, Faculty of Pharmacy, University of KwaZulu-Natal, Durban, South AfricaVarsha Bangalee, Discipline of Pharmaceutical Sciences, College of Health Sciences, Faculty of Pharmacy, University of KwaZulu-Natal, Durban, South Africa
Frasia Oosthuizen, Discipline of Pharmaceutical Sciences, College of Health Sciences, Faculty of Pharmacy, University of KwaZulu-Natal, Durban, South Africa
Abstract
Background: Antibiotics are amongst the more frequently prescribed medicines in pregnant women and the use of antibiotics is increasing. However, with limited studies available in this population, the safe use of antibiotics in pregnancy remains a concern.
Aim: To evaluate the use of antibiotics amongst pregnant women attending a public health care facility. The main objective of this study was to quantify the types of antibiotics used in pregnant women.
Setting: A public hospital classified as a referral hospital located in Durban, KwaZulu-Natal.
Methods: Demographic and treatment information of women were collected retrospectively from January 2019 to July 2019. A total of 184 pregnant patients, who received antibiotic therapy, were included in this study. Descriptive and analytical measures were used to analyse both patient demographics and treatment variables.
Results: A total of 416 antibiotic prescriptions, issued to 184 patients, were reviewed. Penicillins (39.7%), macrolides (13.0%) and combination penicillin- and beta-lactam inhibitors (12.3%) were reported as the most commonly prescribed antibiotics. Rifamycin (2.9%), hydrazides (2.2%) and aminoglycosides (1.9%) were less frequently prescribed. Most antibiotics were prescribed for diseases of the circulatory system (36.1%).
Conclusion: Several classes of antibiotics were used in pregnancy despite the lack of available safety data and clinical evidence. Informing women of the potential side effects and keeping abreast with new information played an important role in the safe, rational and effective use of medicines that contributed to improving maternal health.
Keywords
Metrics
Total abstract views: 3834Total article views: 4681
Crossref Citations
1. Prevalence and factors associated with the irrational use of antibiotics by pregnant women in the city of Marrakech, Morocco: a cross-sectional study
Naima Aoutil, Mohamed Cherkaoui, Mohamed Bouskraoui
BMC Pregnancy and Childbirth vol: 25 issue: 1 year: 2025
doi: 10.1186/s12884-025-08089-8
2. Antibiotic safety among neonates and paediatrics in a public hospital: KwaZulu-Natal
Tyler A. Frank, Frasia Oosthuizen, Varsha Bangalee
Health SA Gesondheid vol: 28 year: 2023
doi: 10.4102/hsag.v28i0.2464
3. Prenatal Maternal Antibiotics Treatment Alters the Gut Microbiota and Immune Function of Post-Weaned Prepubescent Offspring
Abdullah M. Madany, Heather K. Hughes, Paul Ashwood
International Journal of Molecular Sciences vol: 23 issue: 21 first page: 12879 year: 2022
doi: 10.3390/ijms232112879
4. Developmental exposure of antibiotics shortens life span and induces teratogenicity in Drosophila melanogaster
Sanya Shabbir, Abdullah Hadi, Nusrat Jabeen, Mushtaq Hussain
Toxicology Reports vol: 13 first page: 101784 year: 2024
doi: 10.1016/j.toxrep.2024.101784
5. Antimicrobial usage in pregnancy: Guidelines and challenges in India; A systematic review
Raja Chakraverty, Jyotirmoy Bondyopadhyay, Poulomi Roy Chowdhury
Indian Journal of Pharmacy and Pharmacology vol: 10 issue: 3 first page: 166 year: 2023
doi: 10.18231/j.ijpp.2023.032
6. Maternal–Fetal Exposure to Antibiotics: Levels, Mother-to-Child Transmission, and Potential Health Risks
Shiyu Miao, Jia Yin, Shuang Liu, Qingqing Zhu, Chunyang Liao, Guibin Jiang
Environmental Science & Technology vol: 58 issue: 19 first page: 8117 year: 2024
doi: 10.1021/acs.est.4c02018
7. Doctors’ preferences in the choice of antibacterial drugs in pregnant women (PIKAP study)
Roman A Bontsevich, Oxana M Zarudskaya, Anna V Adonina
International Journal of Risk & Safety in Medicine vol: 36 issue: 3 first page: 124 year: 2025
doi: 10.1177/09246479251327814
